BILIARY-EXCRETION OF CEFTIZOXIME IN HUMANS

被引:3
作者
BROGARD, JM [1 ]
ARNAUD, JP [1 ]
TIMMLER, R [1 ]
机构
[1] CTR MED CHIRURG & OBSTET,SERV CHIRURG,SCHILTIGHEIM,FRANCE
关键词
D O I
10.1159/000238272
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:221 / 226
页数:6
相关论文
共 15 条
[1]  
ADAM D, 1982, ARZNEIMITTEL FORSCH, V1, P416
[2]  
Brogard J M, 1982, Antibiot Chemother (1971), V31, P145
[3]   THE BILIARY-EXCRETION OF CEFAMANDOLE - EXPERIMENTAL-STUDY AND APPRAISAL IN HUMANS [J].
BROGARD, JM ;
PINGET, M ;
ARNAUD, JP ;
BAKICH, D ;
LAVILLAUREIX, J .
INFECTION, 1981, 9 (01) :34-41
[4]  
BROGARD JM, 1980, AGENTS ANTIMICROBIEN
[5]  
BROGARD JM, 1976, 1976 INT WORKSH BIL
[6]   ELIMINATION OF BACTERIA IN BILIARY-TRACT INFECTIONS DURING CEFTIZOXIME THERAPY [J].
HELM, EB ;
WURBS, D ;
HAAG, R ;
BENTELE, D ;
SHAH, PM .
INFECTION, 1982, 10 (02) :67-70
[7]  
HITZENBERGER G, 1981, WIEN MED WOCHENSCHR, V15, P391
[8]   CEFTIZOXIME (FK 749), A NEW PARENTERAL CEPHALOSPORIN - INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES [J].
KAMIMURA, T ;
MATSUMOTO, Y ;
OKADA, N ;
MINE, Y ;
NISHIDA, M ;
GOTO, S ;
KUWAHARA, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) :540-548
[9]   ANTIBACTERIAL ACTIVITY OF CEFTIZOXIME (FK 749), A NEW CEPHALOSPORIN, AGAINST CEPHALOSPORIN-RESISTANT BACTERIA, AND ITS STABILITY TO BETA-LACTAMASE [J].
KOJO, H ;
NISHIDA, M ;
GOTO, S ;
KUWAHARA, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) :549-553
[10]   PHARMACOKINETICS OF CEFTIZOXIME IN ANIMALS AFTER PARENTERAL DOSING [J].
MURAKAWA, T ;
SAKAMOTO, H ;
FUKADA, S ;
NAKAMOTO, S ;
HIROSE, T ;
ITOH, N ;
NISHIDA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (02) :157-164